Related Experiment Video
Updated: Mar 19, 2026

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020
Biomaterials-Potential nucleation agents in blood and possible implications
1Institute of Physical Chemistry, Justus-Liebig-University of Giessen, Heinrich-Buff-Ring 17, 35392 Giessen, Germany.
Biomaterials can cause unwanted calcium phosphate buildup on implants. This coating can block essential proteins, growth factors, and drug release, potentially hindering implant function and efficacy.
Area of Science:
- Biomaterials Science
- Surface Chemistry
- Biomineralization
Background:
- Body fluids and cell media are supersaturated with calcium phosphates.
- Biomaterials can act as nucleation sites for salt precipitation.
- This phenomenon can be advantageous or disadvantageous depending on the application.
Purpose of the Study:
- To review the mineralization effect of biomaterials.
- To highlight negative implications of calcium phosphate nucleation on functionalized bone implants.
- To emphasize the need for surface analytical testing of biomaterials for nucleation potential.
Main Methods:
- Literature review on biomaterial nucleation and mineralization.
- Analysis of implications for functionalized implants.
- Discussion of surface analytical techniques for in vitro assessment.
Main Results:
- Biomaterials can induce heterogeneous nucleation of calcium phosphates.
- Surface coatings (proteins, growth factors) on implants can become ineffective due to mineralization.
- Drug release from loaded implants may be inhibited by calcium phosphate deposition.
Conclusions:
- Calcium phosphate nucleation on biomaterials is a critical factor to consider in material development.
- Functionalized implants risk losing efficacy due to unintended surface mineralization.
- In vitro surface analysis is crucial for evaluating biomaterial nucleation properties before clinical application.
More Related Videos
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
09:53Automated Microfluidic Blood Lysis Protocol for Enrichment of Circulating Nucleated Cells
Published on: December 31, 2009